IMIDomics

Barcelona, Spain

IMIDomics is a unique company tackling Immune-Mediated Inflammatory Diseases (IMIDs).

Mar 2024

Corporate Round

Top Investors

Bristol-Myers SquibbUnion Chimique BelgeEvotecTao Capital PartnersDNS Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are IMIDomics's investors?

IMIDomics's investors include Bristol-Myers Squibb, Union Chimique Belge, Evotec, Tao Capital Partners, DNS Capital.

Where is IMIDomics headquartered?

IMIDomics is headquartered in Barcelona, Spain.

What does IMIDomics do?

IMIDomics is a unique company tackling Immune-Mediated Inflammatory Diseases (IMIDs).

What stage is IMIDomics at?

IMIDomics is at the Corporate Round stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 4, 2024.

MLA

"IMIDomics — Funding & Investors." VCBacked, March 4, 2024, https://www.vcbacked.co/company/imidomics. Accessed July 1, 2026.

APA

VCBacked. (2024). IMIDomics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/imidomics

Wikipedia (cite web)

{{cite web |title=IMIDomics — Funding & Investors |url=https://www.vcbacked.co/company/imidomics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 4, 2024.